Predictive Oncology Performance
| POAIDelisted Stock | USD 5.95 0.00 0.00% |
The company holds a Beta of -0.99, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Predictive Oncology are expected to decrease slowly. On the other hand, during market turmoil, Predictive Oncology is expected to outperform it slightly. At this point, Predictive Oncology has a negative expected return of -1.0%. Please make sure to check Predictive Oncology's skewness, and the relationship between the total risk alpha and day median price , to decide if Predictive Oncology performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2026. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
1 | Penny stock jumps 200 percent on thrilling crypto announcement | 09/29/2025 |
2 | Will Predictive Oncology Inc. stock maintain strong growth - Portfolio Profit Report Low Risk Entry Point Guides - nchmf.gov.vn | 10/20/2025 |
3 | Predictive Oncology Updates ATM Offering Program - TipRanks | 10/29/2025 |
4 | Why retail investors pile into Predictive Oncology Inc. stock - Market Movers Consistent Income Trade Recommendations - fcp.pa.gov.br | 11/06/2025 |
5 | Is Predictive Oncology Inc. stock worth buying before Fed action - Quarterly Profit Review Consistent Profit Trading Strategies - newser.com | 11/12/2025 |
6 | Will Predictive Oncology Inc. stock test record highs in 2025 - Bond Market Risk Controlled Swing Trade Alerts - newser.com | 11/19/2025 |
7 | Predictive Oncology Stockholders Approve Key Proposals - TipRanks | 11/25/2025 |
8 | Predictive Oncology Regains Compliance with Nasdaqs Minimum Stockholders Equity Requirement | 12/02/2025 |
| Begin Period Cash Flow | 8.7 M | |
| Total Cashflows From Investing Activities | 22.5 K |
Predictive |
Predictive Oncology Relative Risk vs. Return Landscape
If you would invest 1,515 in Predictive Oncology on September 19, 2025 and sell it today you would lose (920.00) from holding Predictive Oncology or give up 60.73% of portfolio value over 90 days. Predictive Oncology is currently does not generate positive expected returns and assumes 10.9638% risk (volatility on return distribution) over the 90 days horizon. In different words, 98% of stocks are less volatile than Predictive, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Predictive Oncology Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Predictive Oncology's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Predictive Oncology, and traders can use it to determine the average amount a Predictive Oncology's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0914
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | POAI |
Based on monthly moving average Predictive Oncology is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Predictive Oncology by adding Predictive Oncology to a well-diversified portfolio.
Predictive Oncology Fundamentals Growth
Predictive Stock prices reflect investors' perceptions of the future prospects and financial health of Predictive Oncology, and Predictive Oncology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Predictive Stock performance.
| Return On Equity | -7.46 | |||
| Return On Asset | -1.29 | |||
| Operating Margin | (906.54) % | |||
| Current Valuation | 21.66 M | |||
| Shares Outstanding | 3.39 M | |||
| Price To Book | 1.43 X | |||
| Price To Sales | 12.07 X | |||
| Revenue | 1.62 M | |||
| EBITDA | (10.24 M) | |||
| Cash And Equivalents | 25.39 M | |||
| Cash Per Share | 0.32 X | |||
| Total Debt | 2.13 M | |||
| Debt To Equity | 0.01 % | |||
| Book Value Per Share | (100.94) X | |||
| Cash Flow From Operations | (11.96 M) | |||
| Earnings Per Share | (141.32) X | |||
| Total Asset | 4.97 M | |||
| Retained Earnings | (180.43 M) | |||
About Predictive Oncology Performance
By evaluating Predictive Oncology's fundamental ratios, stakeholders can gain valuable insights into Predictive Oncology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Predictive Oncology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Predictive Oncology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence primarily in the United States. Predictive Oncology Inc. was incorporated in 2002 and is based in Eagan, Minnesota. Predictive Oncology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.Things to note about Predictive Oncology performance evaluation
Checking the ongoing alerts about Predictive Oncology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Predictive Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Predictive Oncology is now traded under the symbol AGPU. Please update your portfolios or report it if you believe this is an error. Report It! | |
| Predictive Oncology generated a negative expected return over the last 90 days | |
| Predictive Oncology has high historical volatility and very poor performance | |
| Predictive Oncology has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 1.62 M. Net Loss for the year was (10.86 M) with profit before overhead, payroll, taxes, and interest of 814.04 K. | |
| Predictive Oncology currently holds about 25.39 M in cash with (11.96 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.32. | |
| Latest headline from finance.yahoo.com: Predictive Oncology Regains Compliance with Nasdaqs Minimum Stockholders Equity Requirement |
- Analyzing Predictive Oncology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Predictive Oncology's stock is overvalued or undervalued compared to its peers.
- Examining Predictive Oncology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Predictive Oncology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Predictive Oncology's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Predictive Oncology's stock. These opinions can provide insight into Predictive Oncology's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Predictive Oncology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Other Consideration for investing in Predictive Stock
If you are still planning to invest in Predictive Oncology check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Predictive Oncology's history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |